Literature DB >> 15925070

Familial and hereditary prostate cancer by definition in an italian surgical series: clinical features and outcome.

Emilio Sacco1, Tommaso Prayer-Galetti, Francesco Pinto, Matteo Ciaccia, Simonetta Fracalanza, Giovanni Betto, Francesco Pagano.   

Abstract

OBJECTIVE: To evaluate the clinical impact of different definitions of hereditary prostate cancer (PCa), the relative risk (RR) of relatives of PCa cases and differences in clinical-pathological features and outcome as function of a family history in a surgical series exposed to Mediterranean diet.
METHODS: We classified as Sporadic (SPC), Familial (FPC) or Hereditary (HPC) 606 consecutive PCa cases, 65 years old or less at diagnosis, underwent radical retropubic prostatectomy between January 1, 1987 and December 31, 2002 (mean follow-up: 6.4 years). The disease-free, overall and PCa-specific survival were also compared between SPC and non-SPC (NSPC) cases.
RESULTS: Overall 12.5% of cases had a positive family history. We found 14 (2.3%) HPC cases versus 16 (2.6%) taking account of X-linked transmission. Relatives of early-onset PCa cases had a higher RR to PCa (4.3) compared to late-onset PCa cases. NSPC cases had a lower frequency of positive margins status (p=0.011), perineural infiltration (p=0.028) and positive lymph nodes (p=0.005) than SPC cases, but no differences were found in major prognostic factors (preoperative PSA, Gleason sum, pathological stage) and outcome endpoints as function of a family history.
CONCLUSIONS: A positive family history is an important risk factor to PCa. HPC frequency is probably underestimated because of exclusion of X-linked transmission. We support the similarity between SPC and NSPC with respect to biological aggressiveness.

Entities:  

Mesh:

Year:  2005        PMID: 15925070     DOI: 10.1016/j.eururo.2005.01.016

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  5 in total

1.  Clinical features of familial or hereditary prostate cancer in korean men: a pilot study.

Authors:  Seung Hwan Lee; Kyung Kgi Park; Mun Su Chung; Byung Ha Chung
Journal:  Korean J Urol       Date:  2011-01-24

2.  Germline Mutations in Patients With Early-Onset Prostate Cancer.

Authors:  Tang Tang; Xintao Tan; Ze Wang; Shuo Wang; Yapeng Wang; Jing Xu; Xiajie Wei; Dianzheng Zhang; Qiuli Liu; Jun Jiang
Journal:  Front Oncol       Date:  2022-06-06       Impact factor: 5.738

3.  Impact of a family history of prostate cancer on clinicopathologic outcomes and survival following radical prostatectomy.

Authors:  Mary E Westerman; Boris Gershman; R Jeffrey Karnes; R Houston Thompson; Laureano Rangel; Stephen A Boorjian
Journal:  World J Urol       Date:  2015-12-09       Impact factor: 4.226

4.  Outcome of Prostate Biopsy in Men Younger than 40 Years of Age with High Prostate-Specific Antigen (PSA) Levels.

Authors:  Jin Bak Yang; Byong Chang Jeong; Seong Il Seo; Seong Soo Jeon; Han Yong Choi; Hyun Moo Lee
Journal:  Korean J Urol       Date:  2010-01-21

5.  Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomy.

Authors:  Mark Thalgott; Martina Kron; Johannes M Brath; Donna P Ankerst; Ian M Thompson; Juergen E Gschwend; Kathleen Herkommer
Journal:  World J Urol       Date:  2017-11-21       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.